Mary Reumuth

Insider Reports History

Location
Waltham, MA
Signature
/s/ Mary Reumuth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Reumuth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KALA BIO, Inc. CHIEF FINANCIAL OFFICER Common Stock 28.9K $59.3K $2.05 Oct 23, 2025 Direct
KALA BIO, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 45.2K Jan 6, 2025 Direct

Insider Reports Filed by Mary Reumuth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALA KALA BIO, Inc. Oct 22, 2025 2 -$27.5K 4 Oct 24, 2025 CHIEF FINANCIAL OFFICER
KALA KALA BIO, Inc. Jun 24, 2025 1 -$14.6K 4 Jun 26, 2025 CHIEF FINANCIAL OFFICER
KALA KALA BIO, Inc. Jun 3, 2025 1 -$10.7K 4 Jun 4, 2025 CHIEF FINANCIAL OFFICER
KALA KALA BIO, Inc. Jan 6, 2025 3 -$13K 4 Jan 7, 2025 CHIEF FINANCIAL OFFICER
KALA KALA BIO, Inc. Jun 26, 2024 1 -$19.8K 4 Jun 27, 2024 CHIEF FINANCIAL OFFICER
KALA KALA BIO, Inc. May 31, 2024 1 -$10.9K 4 Jun 3, 2024 CHIEF FINANCIAL OFFICER
KALA KALA BIO, Inc. Jan 4, 2024 3 -$8.27K 4 Jan 5, 2024 CHIEF FINANCIAL OFFICER
KALA Kala Pharmaceuticals, Inc. Jun 22, 2023 2 $0 4 Jun 23, 2023 CHIEF FINANCIAL OFFICER
KALA Kala Pharmaceuticals, Inc. May 31, 2023 9 $0 4 Jun 2, 2023 CHIEF FINANCIAL OFFICER
KALA Kala Pharmaceuticals, Inc. Mar 14, 2023 1 $0 4 Mar 15, 2023 CHIEF FINANCIAL OFFICER
KALA Kala Pharmaceuticals, Inc. Jan 4, 2023 2 -$1.71K 4 Jan 6, 2023 CHIEF FINANCIAL OFFICER
KALA Kala Pharmaceuticals, Inc. Oct 26, 2022 1 -$1.26K 4 Oct 28, 2022 CHIEF FINANCIAL OFFICER
KALA Kala Pharmaceuticals, Inc. Jun 27, 2022 1 -$967 4 Jun 29, 2022 CHIEF FINANCIAL OFFICER
KALA Kala Pharmaceuticals, Inc. Jan 3, 2022 2 -$3.71K 4 Jan 5, 2022 CHIEF FINANCIAL OFFICER
KALA Kala Pharmaceuticals, Inc. Oct 26, 2021 1 -$17K 4 Oct 28, 2021 CHIEF FINANCIAL OFFICER
KALA Kala Pharmaceuticals, Inc. Jun 28, 2021 1 -$14.1K 4 Jun 29, 2021 CHIEF FINANCIAL OFFICER